LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: The role of liquid biopsy in management of the neck with indeterminate response on post-treatment imaging following non-surgical management of oropharyngeal cancer.

    Li, Lucy Q / Adamowicz, Martyna / Wescott, Robert A / Warlow, Sophie J / Thomson, John P / Robert, Christelle / Carey, Lara M / Thain, Helen / Cuschieri, Kate / Conn, Brendan / Hay, Ashley / Aitman, Timothy J / Nixon, Iain J

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

    2022  Volume 49, Issue 1, Page(s) 55–59

    Abstract: Introduction: This study aimed to determine if post-treatment HPV cell-free DNA (cfDNA) can assist in the decision-making process for salvage neck dissection in patients following non-surgical treatment of oropharyngeal squamous cell carcinoma (OPSCC) ... ...

    Abstract Introduction: This study aimed to determine if post-treatment HPV cell-free DNA (cfDNA) can assist in the decision-making process for salvage neck dissection in patients following non-surgical treatment of oropharyngeal squamous cell carcinoma (OPSCC) with a partial response in the neck on imaging at 12 weeks post-treatment.
    Methods: 86 patients who completed treatment were prospectively recruited through the regional multidisciplinary team (MDT). Treatment response was categorised as complete response (CR), partial response (PR) or progressive disease on 12-week post-treatment imaging. Pre- and post-treatment blood samples were assessed for HPV cfDNA through droplet digital PCR (ddPCR).
    Results: Eight patients had an isolated partial response in the neck. One (12.5%) had detectable HPV cfDNA (22.96 copies/ml) at ∼12 weeks post-treatment with positive disease on subsequent neck dissection (positive predictive value; PPV = 100%). Of the seven patients with undetectable HPV cfDNA, two patients had evidence of regional disease recurrence at 23.9 and 27.4 months respectively (negative predictive value; NPV = 71%).
    Conclusion: The detection of HPV cfDNA may help target salvage therapy in patients with a partial response in the neck. Follow-up studies in larger cohorts would be required to further validate the use of post-treatment HPV cfDNA in the management of OPSCC.
    MeSH term(s) Humans ; Papillomavirus Infections/complications ; Carcinoma, Squamous Cell/diagnostic imaging ; Carcinoma, Squamous Cell/therapy ; Carcinoma, Squamous Cell/pathology ; Neoplasm Recurrence, Local/pathology ; Oropharyngeal Neoplasms/diagnostic imaging ; Oropharyngeal Neoplasms/therapy ; Oropharyngeal Neoplasms/pathology ; Squamous Cell Carcinoma of Head and Neck/diagnostic imaging ; Squamous Cell Carcinoma of Head and Neck/therapy ; Liquid Biopsy ; Head and Neck Neoplasms/diagnostic imaging ; Head and Neck Neoplasms/therapy ; Cell-Free Nucleic Acids
    Chemical Substances Cell-Free Nucleic Acids
    Language English
    Publishing date 2022-09-29
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 632519-1
    ISSN 1532-2157 ; 0748-7983
    ISSN (online) 1532-2157
    ISSN 0748-7983
    DOI 10.1016/j.ejso.2022.09.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Longitudinal measurement of HPV copy number in cell-free DNA is associated with patient outcomes in HPV-positive oropharyngeal cancer.

    Warlow, Sophie J / Adamowicz, Martyna / Thomson, John P / Wescott, Robert A / Robert, Christelle / Carey, Lara M / Thain, Helen / Cuschieri, Kate / Li, Lucy Q / Conn, Brendan / Hay, Ashley / Nixon, Iain J / Aitman, Timothy J

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

    2022  Volume 48, Issue 6, Page(s) 1224–1234

    Abstract: Introduction: Oropharyngeal squamous cell carcinoma (OPSCC) is increasing in global prevalence and is divided into two types dependent on association with human papillomavirus (HPV). Assay of HPV copy number in plasma cell-free DNA (cfDNA) provides a ... ...

    Abstract Introduction: Oropharyngeal squamous cell carcinoma (OPSCC) is increasing in global prevalence and is divided into two types dependent on association with human papillomavirus (HPV). Assay of HPV copy number in plasma cell-free DNA (cfDNA) provides a minimally invasive method for detecting and monitoring tumour-derived HPV, with potential for enhancing clinical care.
    Materials and methods: In a prospectively recruited cohort of 104 OPSCC patients, we evaluate the utility of cfDNA droplet digital PCR (ddPCR) as a method for characterisation and longitudinal monitoring of patients with OPSCC.
    Results: ddPCR assay of pre-treatment plasma cfDNA for five HPV types showed overall 95% concordance with p16 immunohistochemistry and PCR analysis of tumour tissue. Longitudinal sampling in 48 HPV+ve patients, with median follow-up of 20 months, was strongly associated with patient outcomes. Persistently elevated cfDNA-HPV post-treatment was associated with treatment failure (2/2 patients) and an increase of cfDNA-HPV in patients whose HPV levels were initially undetectable post-treatment was associated with disease recurrence (5/6 patients). No recurrence was observed in patients in whom cfDNA-HPV was undetectable in all post-treatment samples. In two patients, sequential HPV measurement could have avoided surgical intervention which did not confirm recurrence.
    Conclusion: The high concordance of pre-treatment plasma cfDNA-HPV analysis with tissue-based assays, together with the clinical associations of sequentially measured post-treatment cfDNA-HPV copy number add to a growing body of evidence that suggest utility of cfDNA-HPV ddPCR in management of OPSCC. Standardised clinical trials based on these data are now needed to assess the impact of such testing on overall patient outcomes.
    MeSH term(s) Cell-Free Nucleic Acids ; DNA Copy Number Variations ; Humans ; Neoplasm Recurrence, Local ; Oropharyngeal Neoplasms/diagnosis ; Oropharyngeal Neoplasms/virology ; Papillomaviridae/genetics ; Papillomavirus Infections/complications ; Squamous Cell Carcinoma of Head and Neck/diagnosis ; Squamous Cell Carcinoma of Head and Neck/virology
    Chemical Substances Cell-Free Nucleic Acids
    Language English
    Publishing date 2022-04-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 632519-1
    ISSN 1532-2157 ; 0748-7983
    ISSN (online) 1532-2157
    ISSN 0748-7983
    DOI 10.1016/j.ejso.2022.03.232
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top